121 related articles for article (PubMed ID: 8384765)
1. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription.
Vernon SD; Hart CE; Reeves WC; Icenogle JP
Virus Res; 1993 Feb; 27(2):133-45. PubMed ID: 8384765
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression.
Tornesello ML; Buonaguro FM; Beth-Giraldo E; Giraldo G
Intervirology; 1993; 36(2):57-64. PubMed ID: 8294182
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5'-segment of the upstream regulatory region (URR).
Arany I; Grattendick KG; Tyring SK
Antiviral Res; 2002 Aug; 55(2):331-9. PubMed ID: 12103433
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice.
Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ
Gynecol Oncol; 2003 Jun; 89(3):360-8. PubMed ID: 12798696
[TBL] [Abstract][Full Text] [Related]
6. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
[TBL] [Abstract][Full Text] [Related]
7. Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein.
Sethi N; Palefsky J
Hum Gene Ther; 2003 Jan; 14(1):45-57. PubMed ID: 12573058
[TBL] [Abstract][Full Text] [Related]
8. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
10. Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein.
Lees E; Osborn K; Banks L; Crawford L
J Gen Virol; 1990 Jan; 71 ( Pt 1)():183-93. PubMed ID: 2154535
[TBL] [Abstract][Full Text] [Related]
11. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
[TBL] [Abstract][Full Text] [Related]
12. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
13. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.
Gloss B; Bernard HU; Seedorf K; Klock G
EMBO J; 1987 Dec; 6(12):3735-43. PubMed ID: 2828035
[TBL] [Abstract][Full Text] [Related]
14. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
15. Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.
Fujii T; Austin D; Guo D; Srimatkandada S; Wang T; Kubushiro K; Masumoto N; Tsukazaki K; Nozawa S; Deisseroth AB
Clin Cancer Res; 2003 Nov; 9(14):5423-8. PubMed ID: 14614029
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T
J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
[TBL] [Abstract][Full Text] [Related]
18. Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women.
Kim YB; Song YS; Jeon YT; Park JS; Um SJ; Kim JW; Park NH; Kang SB; Lee HP
Oncol Rep; 2005 Aug; 14(2):459-64. PubMed ID: 16012730
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.
Romanczuk H; Thierry F; Howley PM
J Virol; 1990 Jun; 64(6):2849-59. PubMed ID: 2159546
[TBL] [Abstract][Full Text] [Related]
20. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
